Doxorubicin.

Drug identity checked against registry records

Also recorded as Adriamycin; Doxil

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
9-ING-41 in Patients With Advanced CancersNCT03678883ACTUPhase 2Active not recruiting2026-06Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.